Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fuling Yunhua Granules and Dihuang Baoyuan Granules in Type 2 Diabetes
NCT06575478Phase 2Completed
- Sponsor
- Beijing Supreme Life Pharmaceutical Technology Co., Ltd.
- Start
- Jul 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Fuling Yunhua Granules, Dihuang Baoyuan Granules in type 2 diabetes mellitus (T2DM), sponsored by Beijing Supreme Life Pharmaceutical Technology Co., Ltd.. Started Jul 2024; status: completed.
02
Drugs
Fuling Yunhua GranulesDihuang Baoyuan Granules
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06575478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06575478.